Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
compounding
Pharma
FDA advisory committee to discuss action on unapproved peptides
An FDA advisory committee will convene this summer to discuss certain peptides that are currently restricted from use in compounded medications.
Zoey Becker
Apr 15, 2026 5:15pm
Lilly warns of 'impurity' in some compounded tirzepatide drugs
Mar 12, 2026 10:00am
FDA unleashes warning letters to firms selling compounded GLP-1s
Mar 4, 2026 8:30am
Hims quits on obesity pill after legal, regulatory heat
Feb 9, 2026 10:24am
FDA commissioner pledges crackdown on compounding practices
Feb 6, 2026 9:59am
Fierce Healthcare
Hims & Hers plans to launch $49 copy of Wegovy pill
Feb 5, 2026 1:00pm